Patrick R Lawler - JoVE Visualize

Showing results (121-130 of 156) with videos related to

Pageof 16

Sort By:

CJC Open|September 10, 2021

Development of Acute Myocardial Infarction Mortality and Readmission Models for Public Reporting on Hospital Performance in CanadaDennis T Ko, Tareq Ahmed, Peter C Austin, et al.

Clinical Trials (London, England)|August 21, 2020

Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L Houston, Patrick R Lawler, Ewan C Goligher, et al.

Circulation|October 2, 2023

Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, Mohit Pahuja, Sean van Diepen, et al.

Circulation. Heart Failure|December 2, 2022

Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.

Chest|November 18, 2023

Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of LifeYonatan Y Greenstein, Kinsley Hubel, Joshua Froess, et al.

Journal of Cardiac Failure|February 27, 2025

Epidemiology and Prognostic Significance of Acute Noncardiac Organ Dysfunction Across Cardiogenic Shock SubtypesAnubodh S Varshney, Michael G Palazzolo, Christopher F Barnett, et al.

Journal of Thrombosis and Haemostasis : JTH|September 5, 2020

Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaborationTobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, et al.

Journal of Cardiac Failure|October 9, 2021

De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network RegistryAnkeet S Bhatt, David D Berg, Erin A Bohula, et al.

Resuscitation|December 15, 2022

Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN)Anthony P Carnicelli, Ryan Keane, Kelly M Brown, et al.

JAMA|January 18, 2022

Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical TrialJeffrey S Berger, Lucy Z Kornblith, Michelle N Gong, et al.

Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:

Pageof 16

CJC Open|September 10, 2021

Development of Acute Myocardial Infarction Mortality and Readmission Models for Public Reporting on Hospital Performance in CanadaDennis T Ko, Tareq Ahmed, Peter C Austin, et al.

Clinical Trials (London, England)|August 21, 2020

Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L Houston, Patrick R Lawler, Ewan C Goligher, et al.

Circulation|October 2, 2023

Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, Mohit Pahuja, Sean van Diepen, et al.

Circulation. Heart Failure|December 2, 2022

Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.

Chest|November 18, 2023

Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of LifeYonatan Y Greenstein, Kinsley Hubel, Joshua Froess, et al.

Journal of Cardiac Failure|February 27, 2025

Epidemiology and Prognostic Significance of Acute Noncardiac Organ Dysfunction Across Cardiogenic Shock SubtypesAnubodh S Varshney, Michael G Palazzolo, Christopher F Barnett, et al.

Journal of Thrombosis and Haemostasis : JTH|September 5, 2020

Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaborationTobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, et al.

Journal of Cardiac Failure|October 9, 2021

De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network RegistryAnkeet S Bhatt, David D Berg, Erin A Bohula, et al.

Resuscitation|December 15, 2022

Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN)Anthony P Carnicelli, Ryan Keane, Kelly M Brown, et al.

JAMA|January 18, 2022

Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical TrialJeffrey S Berger, Lucy Z Kornblith, Michelle N Gong, et al.

Pageof 16